Top 10 Pharmaceutical Companies in Europe in 2022 by Market Capitalization

Novo Nordisk AS, F. Hoffmann-La Roche Ltd, AstraZeneca Plc, Novartis AG, and Sanofi are the top 5 pharma companies in Europe in 2023 by market capitalization (as of Mar 31, 2023). Comprehensively, the top 10 Pharma companies in Europe had a total market cap of $1,286,497 million (as of Mar 31, 2023), with Novo Nordisk AS having the highest ($277,061 million), followed by F. Hoffmann-La Roche Ltd ($232,914 million), and AstraZeneca Plc ($215,560 million), while Sanofi is the lowest ($136,991 million). The Denmark-based Novo Nordisk AS is the leading Pharma company in Europe by market cap (as of Mar 31, 2023). The company reported revenues of $ 25,014 million for the fiscal year ended December 2022 (FY2022), an increase of 25.7% over FY2021. The company’s portfolio includes pre-filled delivery systems for insulin; glucagon hypokit; cartridge; needles; vials; insulin; estradiol for hormone replacement; recombinant drugs for hemophilia; glucagon; and oral antidiabetic agents. It employs 54,393 people. The Swiss-based F. Hoffmann-La Roche Ltd is Europe's leading pharma company by market cap (as of Mar 31, 2023). The company reported revenues of $66,291 million for the fiscal year ended December 2022 (FY2022), an increase of 0.8% over FY2021. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. It employs 103,613 people.